NO20051811L - Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic - Google Patents

Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic

Info

Publication number
NO20051811L
NO20051811L NO20051811A NO20051811A NO20051811L NO 20051811 L NO20051811 L NO 20051811L NO 20051811 A NO20051811 A NO 20051811A NO 20051811 A NO20051811 A NO 20051811A NO 20051811 L NO20051811 L NO 20051811L
Authority
NO
Norway
Prior art keywords
technetium
aza
diaminedioxime
conjugates
targeting
Prior art date
Application number
NO20051811A
Other languages
English (en)
Norwegian (no)
Other versions
NO20051811D0 (no
Inventor
Georg Brauers
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20051811D0 publication Critical patent/NO20051811D0/no
Publication of NO20051811L publication Critical patent/NO20051811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20051811A 2002-10-25 2005-04-14 Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic NO20051811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0224799.7A GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions
PCT/GB2003/004573 WO2004037297A1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic

Publications (2)

Publication Number Publication Date
NO20051811D0 NO20051811D0 (no) 2005-04-14
NO20051811L true NO20051811L (no) 2005-06-27

Family

ID=9946533

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051811A NO20051811L (no) 2002-10-25 2005-04-14 Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic

Country Status (16)

Country Link
EP (1) EP1553986B1 (enExample)
JP (1) JP2006508084A (enExample)
KR (1) KR20050070080A (enExample)
CN (1) CN1708322A (enExample)
AT (1) ATE402720T1 (enExample)
AU (1) AU2003279444A1 (enExample)
BR (1) BR0315578A (enExample)
CA (1) CA2501684A1 (enExample)
DE (1) DE60322562D1 (enExample)
ES (1) ES2309361T3 (enExample)
GB (1) GB0224799D0 (enExample)
MX (1) MXPA05004418A (enExample)
NO (1) NO20051811L (enExample)
RU (1) RU2005110960A (enExample)
WO (1) WO2004037297A1 (enExample)
ZA (1) ZA200502835B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
GB0520527D0 (en) * 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
GB0614337D0 (en) * 2006-07-19 2006-08-30 Acal Energy Ltd Fuel Cells
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
ES2804509T3 (es) 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
ES2739504T3 (es) 2010-12-21 2020-01-31 Ge Healthcare Ltd Uso de anilina en la radioestabilización de una ligadura de oxima
JP5934246B2 (ja) * 2010-12-22 2016-06-15 テーエフシム グリコ−ｃｆ２−セリンおよびグリコ−ｃｆ２−トレオニンの誘導体
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
US20130195756A1 (en) * 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
CN112830940B (zh) * 2020-09-07 2022-03-01 中国科学院宁波材料技术与工程研究所 2,5-呋喃二甲醛肟金属络合物及其制备方法、及在抗菌除霉消毒剂中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69937996T2 (de) * 1998-05-15 2009-01-02 Ge Healthcare Ltd., Little Chalfont Markierte glutamin- und lysinanaloge
WO2001077145A2 (en) * 2000-04-12 2001-10-18 Amersham Health As Integrin binding peptide derivatives
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates

Also Published As

Publication number Publication date
BR0315578A (pt) 2005-10-25
KR20050070080A (ko) 2005-07-05
WO2004037297A1 (en) 2004-05-06
NO20051811D0 (no) 2005-04-14
ES2309361T3 (es) 2008-12-16
CN1708322A (zh) 2005-12-14
MXPA05004418A (es) 2005-11-23
EP1553986A1 (en) 2005-07-20
DE60322562D1 (de) 2008-09-11
RU2005110960A (ru) 2005-11-20
ZA200502835B (en) 2006-03-29
GB0224799D0 (en) 2002-12-04
ATE402720T1 (de) 2008-08-15
EP1553986B1 (en) 2008-07-30
CA2501684A1 (en) 2004-05-06
JP2006508084A (ja) 2006-03-09
AU2003279444A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
Liu Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
Liu et al. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
Meszaros et al. Hydrazinonicotinic acid (HYNIC)–Coordination chemistry and applications in radiopharmaceutical chemistry
Isabel M. Prata Gallium-68: a new trend in PET radiopharmacy
CA2958475C (en) Mono-, di- or oligosaccharide used as metal inhibitors in the preparation of radioactive metal-chelate-functionalized target agents
MacPherson et al. A brief overview of metal complexes as nuclear imaging agents
BRPI0407056A (pt) Composição estabilizada, e precursora, composto radiofarmacêutico, kit e método para a preparação do mesmo, uso do composto radiofarmacêutico, e, método de formação de imagem diagnóstica do corpo de mamìfero
J Berry et al. Dithiocarbamate complexes as radiopharmaceuticals for medical imaging
NO20051811L (no) Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic
Liu et al. Labeling biomolecules with radiorhenium-A review of the bifunctional chelators
IL175667A (en) Imaging factor that includes a synthetic caspase-3 inhibitor marked with the neuroimaging agent, a radiopharmaceutical containing it, a kit for preparation of the preparation and a method for diagnosis based on it
Ono et al. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins
NO20070348L (no) Improved N4 Chelator Conjugates
GB0105224D0 (en) Improved peptide-chelate conjugates
Sun et al. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands
GB0421987D0 (en) Novel technetium and rhenium complexes
CA2066779A1 (en) Stable therapeutic radionuclide compositions and methods for preparation thereof
Ferdani et al. Synthesis, Cu (II) complexation, 64Cu-labeling and biological evaluation of CB-TE1A1P
Holland et al. 89Zr-chemistry in the design of novel radiotracers for immunoPET
Francesconi et al. Metal‐Based Imaging Agents
RAMAMOORTHY INVITED LECTURE XA9847981
Ramamoorthy Developments in {sup 99} Tc {sup m} complexes for functional imaging
Ramamoorthy Developments in 99Tcm complexes for functional imaging
Krajewski et al. Carbonyl complexes of 105Rh as potential radiopharmaceutical precursors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application